BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:Armed antibodies and targeted cytotoxics for the treatment of canc
 er and of rheumatoid arthritis: from the bench to the clinic
DTSTART:20151201T161500
DTEND:20151201T180000
DTSTAMP:20260427T224127Z
UID:c391977ab328956864a58b7d46c22aa4ca7ce3e8dbecf2d1ead8d4ab
CATEGORIES:Conferences - Seminars
DESCRIPTION:Prof. Dario Neri\, ETHZ\nThe research of the group Neri focuse
 s on the engineering of therapeutic antibodies for the treatment of cancer
  and of chronic inflammatory conditions. Other research activities include
  the development of DNA-encoded chemical libraries and of small molecule-d
 rug conjugates. Furthermore\, the group uses mass spectrometry methodologi
 es for the discovery of vascular markers of disease and for HLA peptidome 
 analysis.\nBio: Born in Rome (Italy) on 1 May 1963\, Dario Neri studied Ch
 emistry at the Scuola Normale Superiore of Pisa\, graduating with a thesis
  on the synthesis and characterization of complex polyunsaturated secondar
 y metabolites\, isolated from higher plants. He earned his doctorate in Ch
 emistry under the supervision of Prof. Dr. Kurt Wüthrich at the Institute
  of Molecular Biology and Biophysics of the ETH Zürich in 1992\, receivin
 g the Silver Medal of ETH Zürich for his dissertation.\nWith an EU Bridge
  Bursary\, Dario Neri worked from 1992 until 1996 at the Cambridge Centre 
 for Protein Engineering\, Medical Research Council Centre\,  under the su
 pervision of Sir Gregory Winter. He has now been a Professor at the ETH Zu
 rich since 1996.
LOCATION:SV1717.A http://plan.epfl.ch/?lang=fr&room=sv+17171
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR